Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Giugno 2017

Archivio

✕

14 giugno 2017

3596

Amount of Youngsters With Hepatitis C Grows

Amount of Youngsters With Hepatitis C Grows

Nowadays more than 40 percent of young american drug users have Hepatitis C and the amount still keeps on growing. The majority of young people become drug addicted approximately in the age of 17-18. The main reason why so many people from the young generation become positive ...

13 giugno 2017

3871

Bone Problems Appear to HIV-Positive People At an Earlier Age

Bone Problems Appear to HIV-Positive People At an Earlier Age

Bones become more fragile on about ten years earlier by HIV-positive people if compared with those who’s HIV-status is negative, concluded the american researchers in the study “An increased rate of fracture occurs a decade earlier in HIV + compared with HIV – men”, published ...

13 giugno 2017

3497

High Smoking-Level Is Registered Among HIV-positive Men and Women From Low- and Middle Income Countries

High Smoking-Level Is Registered Among HIV-positive Men and Women From Low- and Middle Income Countries

To see how popular smoking is in low- and middle income countries investigators had studied 28 countries of Africa, America and Southeastern Asia and the data of smoking and non-smoking population collected for eleven years.

10 giugno 2017

5561

First Truvada Anti-HIV Drug Generic Approved By FDA, But Will Not Be Immediately Available

First Truvada Anti-HIV Drug Generic Approved By FDA, But Will Not Be Immediately Available

#Teva Pharmaceuticals’ generic version of Truvada anti-HIV drug (emtricitabine and tenofovir disoproxil fumarate) has been approved by the FDA on Friday. Teva representative declined to comment how much its version of the drug will cost or when it will be available to patients ...

9 giugno 2017

3776

PrEP Was Reported to Influence Well On Health Among Gay Men

PrEP Was Reported to Influence Well On Health Among Gay Men

Scientists from Seattle started a research on the way how usage of PrEP influences on one’s health three years ago. First group included about 15 men - gays, bisexual and transgender of different nationalities and races.

9 giugno 2017

3678

An Investigational Vaccine Successfully Suppressed SHIV

An Investigational Vaccine Successfully Suppressed SHIV

An investigational vaccine against simian-human immunodeficiency virus (SHIV) successfully suppressed simian-human immunodeficiency virus (SHIV) during the third phase of the clinical trial. The results of this study has been reported by the scientists from the Duke University ...

8 giugno 2017

3963

Syphilis-Outbreak in England

Syphilis-Outbreak in England

The Guardian have reported about syphilis-outbreak in England. Specialists and doctors said, there was no such a syphilis outbreak in England for nearly 67 years! The level of syphilis transmission has increased on 12%, the majority of syphilis transmission cases happen ...

8 giugno 2017

3962

PrEP Has Been Labeled An ‘Essential Medicine’ By World Health Organisation

PrEP Has Been Labeled An ‘Essential Medicine’ By World Health Organisation

New guidance on antibiotics for common infections and medicines for the more severe circumstances, is among the additions to the WHO Model list of essential medicines for 2017. Other extensions include medications for HIV, hepatitis C, and tuberculosis

7 giugno 2017

3891

Three Antiviral Drugs Combined In One Pill Can Cure Hepatitis C In a Relapse

Three Antiviral Drugs Combined In One Pill Can Cure Hepatitis C In a Relapse

French researchers are waiting for the FDA approval of their method of Hepatitis C cure by those who had a relapse of that disease. Three antiviral drugs combined in one pill can cure hepatitis C in a relapse

7 giugno 2017

4008

New TB Vaccine May Appear Recently

New TB Vaccine May Appear Recently

Scientists from the Dartmouth University, USA, completed their research on TB vaccine DAR-901. The vaccine showed good results in two studies of TB prevention in the earliest infection stages.

1 2 3 4